4/17/2025WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount

4/17/2025Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...

4/15/2025Gardasil9 Gains Expanded Approval in China

4/15/2025China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...

4/15/2025Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...

4/14/2025Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...

4/14/2025Belief BioMed/Takeda's hemophilia B Gene Therapy BBM-H901 Approved in...

4/14/2025Trump vs China Biotech: Who Will Emerge Victorious in the Tariff Trade...

4/14/2025China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as D...

4/11/2025China Greenlights First Gene Therapy for Hemophilia B

4/11/2025YiChang HEC ChangJiang Privatization Advances with NDRC Approval, Fina...

4/11/2025Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...

4/11/2025Recent Executive Moves

4/10/2025Simcere's Anti-Tumor Candidate SIM0686 Gains Clinical Trial Approval i...

4/10/2025China Unveils Ambitious Plan to Boost Health-Related Consumption

4/10/2025Sumitomo Pharma Transfers Asian/Chinese Operations Amid Industry-Wide ...

4/10/2025XellSmart's XS411 Receives IND Clearance in China for Parkinson's Dise...

4/9/2025China Launches Phase I Trial for Nation's First Monkeypox Vaccine

4/9/2025U.S. Urged to Boost Biotech Investment to Counter China's Strategic Ad...

4/9/2025RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG

4/8/2025TJ Biopharma, Biogen Enter Partnership to Advance Felzartamab in China

4/8/2025Hengrui Grants Merck KGaA Exclusive Rights to SHR7280 in Mainland Chin...

4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...

4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses

4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...

4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...

4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations

4/5/2025Recent Executive Moves

4/5/2025China Biopharma Licensing Tracker, Q1 2025 (MC)

4/5/2025China Biopharma Financing Tracker, Q1 2025 (MC)

Page:6/359 Total number of articles:10758: [First][<<] [4] [5] [6] [7] [8] [>>] [End]